Specificity of serum prostate-specific antigen determination in the Finnish prostate cancer screening trial

Specificity constitutes a component of validity for a screening test. The number of false-positive (FP) results has been regarded as one of major shortcomings in prostate cancer screening. We estimated the specificity of serum prostate-specific antigen (PSA) determination in prostate cancer screenin...

Descripción completa

Detalles Bibliográficos
Autores principales: Määttänen, L, Hakama, M, Tammela, T L J, Ruutu, M, Ala-Opas, M, Juusela, H, Martikainen, P, Stenman, U-H, Auvinen, A
Formato: Texto
Lenguaje:English
Publicado: Nature Publishing Group 2007
Materias:
Clinical Study
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2360217/
https://www.ncbi.nlm.nih.gov/pubmed/17213825
http://dx.doi.org/10.1038/sj.bjc.6603522

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2360217/
https://www.ncbi.nlm.nih.gov/pubmed/17213825
http://dx.doi.org/10.1038/sj.bjc.6603522

Ejemplares similares